Literature DB >> 4814347

Rapid and sensitive gas chromatographic determination of hexobarbital in plasma of man using a nitrogen detector.

D D Breimer, J M Van Rossum.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4814347     DOI： 10.1016/s0021-9673(00)83147-7

Source DB:  PubMed          Journal:  J Chromatogr


× No keyword cloud information.
  8 in total

1.  Induction of drug metabolism in man after rifampicin treatment measured by increased hexobarbital and tolbutamide clearance.

Authors:  W Zilly; D D Breimer; E Richter
Journal:  Eur J Clin Pharmacol       Date:  1975-12-19       Impact factor: 2.953

2.  Stimulation of drug metabolism by rifampicin in patients with cirrhosis or cholestasis measured by increased hexobarbital and tolbutamide clearance.

Authors:  W Zilly; D D Breimer; E Richter
Journal:  Eur J Clin Pharmacol       Date:  1977-04-20       Impact factor: 2.953

3.  Pharmacokinetics and relative bioavailability of heptabarbital and heptabarbital sodium after oral administration to man.

Authors:  D D Breimer; A G de Boer
Journal:  Eur J Clin Pharmacol       Date:  1975-12-19       Impact factor: 2.953

4.  Disposition of hexobarbitone in healthy man: kinetics of parent drug and metabolites following oral administration.

Authors:  N P Vermeulen; C T Rietveld; D D Breimer
Journal:  Br J Clin Pharmacol       Date:  1983-04       Impact factor: 4.335

5.  Pharmocokinetics of hexobarbital in man after intravenous infusion.

Authors:  D D Breimer; C Honhoff; W Zilly; E Richter; J M van Rossum
Journal:  J Pharmacokinet Biopharm       Date:  1975-02

6.  Disposition of hexobarbital in intra- and extrahepatic cholestasis in man and the influence of drug metabolism-inducing agents.

Authors:  E Richter; D D Breimer; W Zilly
Journal:  Eur J Clin Pharmacol       Date:  1980       Impact factor: 2.953

7.  Threshold hypnotic concentration of methohexitone.

Authors:  P M Lauven; H Schwilden; H Stoeckel
Journal:  Eur J Clin Pharmacol       Date:  1987       Impact factor: 2.953

8.  DHODH-mediated ferroptosis defence is a targetable vulnerability in cancer.

Authors:  Chao Mao; Xiaoguang Liu; Yilei Zhang; Guang Lei; Yuelong Yan; Hyemin Lee; Pranavi Koppula; Shiqi Wu; Li Zhuang; Bingliang Fang; Masha V Poyurovsky; Kellen Olszewski; Boyi Gan
Journal:  Nature       Date:  2021-05-12       Impact factor: 49.962
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.